Content Type: Research Publications

Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints

March 15, 2026

An International Review of Health Technology Assessment Approaches to Prescription Drugs and Their Ethical Principles

March 15, 2026

Clinical Benefit and Expedited Approval of Cancer Drugs in the United States, European Union, Switzerland, Japan, Canada, and Australia

March 15, 2026

An Orange Book Landscape: Drugs, Patents, and Generic Competition

March 15, 2026

Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval

March 15, 2026

European Medicines Agency’s Priority Medicines Scheme at 2 Years: An Evaluation of Clinical Studies Supporting Eligible Drugs

March 15, 2026

Communication of Drug Efficacy Information Via a Popular Online Platform

March 15, 2026

Mifepristone, Preemption, and Public Health Federalism

March 15, 2026

Characteristics of Key Patents Covering Recent FDA-Approved Drugs:

March 15, 2026

Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments

March 15, 2026

Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization in the US and Europe From 2007 to 2021

March 15, 2026

Brand-Name Market Exclusivity for Nebulizer Therapy to Treat Asthma and COPD

March 15, 2026